505 filings
Page 10 of 26
8-K
aeztlgumwa2 ymnb2xrh
18 May 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
yfvkll cl7yp30gjuko
26 Apr 18
Cytokinetics, Inc. Reports First Quarter 2018 Financial Results
4:00pm
8-K
53ipdw gcms
26 Mar 18
Changes in Registrant's Certifying Accountant
12:00am
8-K
asjvsf4dh
2 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
o9om4iqw6nfao4l
15 Feb 18
Cytokinetics, Inc. Reports Fourth Quarter 2017 Financial Results
12:00am
8-K
qwl412ck40hx bj
12 Feb 18
Cytokinetics Names Robert Califf, M.D., to Board of Directors
12:00am
8-K
3461 xxjk3
3 Jan 18
Cytokinetics Announces Progress Against Vision 2020
12:00am
8-K
b2i6g0y
8 Dec 17
Cytokinetics Announces Presentation of Results From VITALITY-ALS at 28th International Symposium on ALS/MND
12:00am
8-K
qgp841n
21 Nov 17
Cytokinetics Announces Negative Results From VITALITY-ALS
12:00am
8-K
ymir n848oj7e8
6 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
dd87bk iwh9
31 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
1qlaz7zne8qx0 nvy5
26 Oct 17
Cytokinetics, Inc. Reports Third Quarter 2017 Financial Results
12:00am
8-K
uqwhcd
19 Sep 17
Cytokinetics Announces Dosing of First Patient in Japan in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
12:00am
8-K
jdkip6
2 Aug 17
Cytokinetics Announces Positive Results From Phase 2 Clinical Trial of Omecamtiv Mecarbil in Japanese Patients With Heart Failure
12:00am
8-K
x1wmsmvsv0p01
2 Aug 17
Cytokinetics, Inc. Reports Second Quarter 2017 Financial Results
12:00am
8-K
kav76tkm fzxm7wp
27 Jul 17
Cytokinetics Announces Start of FORTITUDE-ALS, a Phase 2 Clinical Trial of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis
12:00am
8-K
5agywj8e8tsyp9
5 Jul 17
Cytokinetics Announces Baseline Data From First Cohort of Phase 2 Clinical Trial of CK-2127107 in Patients With SMA
12:00am
8-K
pfv7nea6 ro
29 Jun 17
Cytokinetics Announces Start of Phase 1b Clinical Trial of CK-2127107 in Elderly Subjects With Limited Mobility
12:00am
8-K
k9glxzcw2x13f
29 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
jcglm87
19 May 17
Submission of Matters to a Vote of Security Holders
12:00am